“For the first time I think we have a chance to really change the course of Alzheimer’s disease,” says Dr. Reisa Sperling. She’s leading the “A4 Clinical Trial” to see if a drug called Solanezumab can slow down or even prevent Alzheimer’s disease. CBS News reports.
More on the A4 Clinical Trial:
- CBS News in Washington